Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
bluebird bio Stock Price (Quote) NASDAQ:BLUE
$20.90 ( 1.41% ) Friday, 15th Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $17.27 | $21.25 | Friday, 15th Oct 2021 BLUE stock ended at $20.90. This is 1.41% more than the trading day before Thursday, 14th Oct 2021. During the day the stock fluctuated 4.73% from a day low at $20.29 to a day high of $21.25. |
| 90 days | $17.14 | $27.96 | |
| 52 weeks | $17.14 | $59.32 |
Historical bluebird bio prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-15 | $20.76 | $21.25 | $20.29 | $20.90 | 2 553 822 |
| 2021-10-14 | $20.23 | $20.83 | $20.23 | $20.61 | 898 814 |
| 2021-10-13 | $20.18 | $21.09 | $20.09 | $20.12 | 1 213 869 |
| 2021-10-12 | $19.86 | $20.60 | $19.84 | $20.43 | 1 118 462 |
| 2021-10-11 | $19.07 | $19.96 | $18.98 | $19.90 | 1 049 072 |
| 2021-10-08 | $18.75 | $19.12 | $18.45 | $19.10 | 692 506 |
| 2021-10-07 | $18.60 | $19.18 | $18.37 | $18.88 | 611 430 |
| 2021-10-06 | $18.03 | $18.62 | $18.00 | $18.48 | 732 395 |
| 2021-10-05 | $18.34 | $18.81 | $17.97 | $18.27 | 446 830 |
| 2021-10-04 | $18.93 | $19.02 | $18.32 | $18.44 | 738 948 |
| 2021-10-01 | $19.07 | $19.21 | $18.40 | $19.13 | 677 181 |
| 2021-09-30 | $19.14 | $19.26 | $18.58 | $19.11 | 572 196 |
| 2021-09-29 | $19.50 | $19.88 | $18.87 | $18.98 | 879 570 |
| 2021-09-28 | $19.00 | $19.84 | $18.90 | $19.60 | 1 858 676 |
| 2021-09-27 | $18.43 | $19.48 | $18.43 | $19.33 | 1 013 438 |
| 2021-09-24 | $18.49 | $18.71 | $18.30 | $18.44 | 641 713 |
| 2021-09-23 | $18.20 | $18.71 | $17.96 | $18.66 | 1 065 105 |
| 2021-09-22 | $17.89 | $18.27 | $17.55 | $18.00 | 924 969 |
| 2021-09-21 | $17.97 | $18.25 | $17.87 | $17.99 | 538 696 |
| 2021-09-20 | $17.89 | $18.38 | $17.75 | $17.97 | 921 590 |
| 2021-09-17 | $17.68 | $18.43 | $17.42 | $18.32 | 2 642 048 |
| 2021-09-16 | $17.80 | $17.83 | $17.27 | $17.68 | 579 857 |
| 2021-09-15 | $17.54 | $18.04 | $17.46 | $17.80 | 724 097 |
| 2021-09-14 | $18.26 | $18.42 | $17.40 | $17.56 | 797 846 |
| 2021-09-13 | $17.89 | $18.62 | $17.66 | $18.29 | 802 034 |
| 2021-09-10 | $18.25 | $18.33 | $17.77 | $17.88 | 845 565 |
| 2021-09-09 | $17.80 | $18.39 | $17.78 | $18.20 | 845 722 |
| 2021-09-08 | $17.48 | $18.10 | $17.30 | $17.87 | 1 107 652 |
| 2021-09-07 | $17.88 | $18.19 | $17.14 | $17.37 | 1 926 163 |
| 2021-09-03 | $18.40 | $18.40 | $17.73 | $18.00 | 829 261 |
| 2021-09-02 | $18.22 | $18.65 | $18.12 | $18.40 | 790 403 |
| 2021-09-01 | $18.39 | $18.51 | $18.12 | $18.32 | 713 809 |
| 2021-08-31 | $17.77 | $18.39 | $17.75 | $18.30 | 1 570 426 |
| 2021-08-30 | $18.13 | $18.23 | $17.68 | $17.85 | 1 018 795 |
| 2021-08-27 | $17.94 | $18.84 | $17.76 | $18.13 | 1 311 082 |
| 2021-08-26 | $18.13 | $18.43 | $17.58 | $17.93 | 1 222 571 |
| 2021-08-25 | $17.75 | $18.26 | $17.46 | $18.21 | 1 279 999 |
| 2021-08-24 | $18.00 | $18.16 | $17.47 | $17.82 | 956 836 |
| 2021-08-23 | $17.85 | $18.37 | $17.76 | $17.97 | 991 339 |
| 2021-08-20 | $17.25 | $18.06 | $17.17 | $17.59 | 927 162 |
| 2021-08-19 | $18.00 | $18.14 | $17.34 | $17.36 | 952 708 |
| 2021-08-18 | $18.66 | $18.78 | $18.06 | $18.09 | 781 798 |
| 2021-08-17 | $18.11 | $18.86 | $17.88 | $18.72 | 846 307 |
| 2021-08-16 | $18.40 | $18.90 | $18.03 | $18.26 | 1 443 381 |
| 2021-08-13 | $18.82 | $19.03 | $18.27 | $18.47 | 863 400 |
| 2021-08-12 | $19.02 | $19.25 | $18.72 | $18.83 | 1 153 811 |
| 2021-08-11 | $19.31 | $19.69 | $18.70 | $19.06 | 1 817 718 |
| 2021-08-10 | $17.85 | $20.15 | $17.72 | $20.04 | 4 535 164 |
| 2021-08-09 | $19.38 | $19.58 | $18.11 | $18.16 | 9 389 523 |
| 2021-08-06 | $25.97 | $26.00 | $24.86 | $25.03 | 797 014 |
bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases. Its product candidates include Lenti-D, which is in phase II/III clinical studies for the treatment of cerebral adrenoleukodystrophy, a rare, hereditary neurological disorder; and LentiGlobin that is in phase I/II clinical studies for the treatment of beta-thalassemia major and severe sickle cell di... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
